Cargando…

Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population

BACKGROUND: In the Netherlands, infection with varicella-zoster virus (VZV) is considered a benign common childhood illness and routine vaccination against VZV is not done. In 1995 it was estimated that 98-100% of the adult Dutch general population is immune, yet the estimate is based on a database...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rijckevorsel, Gini GC, Damen, Marjolein, Sonder, Gerard J, van der Loeff, Maarten F Schim, van den Hoek, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434062/
https://www.ncbi.nlm.nih.gov/pubmed/22721551
http://dx.doi.org/10.1186/1471-2334-12-140
_version_ 1782242383840149504
author van Rijckevorsel, Gini GC
Damen, Marjolein
Sonder, Gerard J
van der Loeff, Maarten F Schim
van den Hoek, Anneke
author_facet van Rijckevorsel, Gini GC
Damen, Marjolein
Sonder, Gerard J
van der Loeff, Maarten F Schim
van den Hoek, Anneke
author_sort van Rijckevorsel, Gini GC
collection PubMed
description BACKGROUND: In the Netherlands, infection with varicella-zoster virus (VZV) is considered a benign common childhood illness and routine vaccination against VZV is not done. In 1995 it was estimated that 98-100% of the adult Dutch general population is immune, yet the estimate is based on a database in which a relative small number of people of non-Dutch ethnic origin were represented. As the city of Amsterdam has large immigrant communities originating from various subtropical and tropical countries, such as Morocco, Surinam, and Turkey with probably lower VZV transmission, this study aimed to estimate the seroprevalence of VZV IgG antibodies (anti-VZV) among various ethnic groups in Amsterdam, and identify factors associated with seronegative VZV status. METHODS: The study was a cross-sectional survey of the Amsterdam population (2004), and the study sample was stratified by age and ethnicity, with deliberate oversampling of minority ethnic groups. Serum samples obtained from 1,341 residents in 2004 were tested for antibodies to VZV. Basic demographic data (gender, age, country of birth, age at immigration and number of children) were also available. RESULTS: The anti-VZV seroprevalence in the overall Amsterdam population was estimated to be 94% (95% confidence intervals; 92–96%). Regarding ethnic origin, first generation immigrants (Moroccan immigrants 90%, Surinamese or Antillean immigrants 91%, and Turkish 92%), especially those that migrated after the age of 11 years, were more likely to be anti-VZV seronegative compared to those arriving at an earlier age or those born in the Netherlands (97–98%). Both ethnic origin and generation of immigration were positive predictors for IgG seronegativity to VZV (p<0.015). No other predictors for seronegativity were found. CONCLUSION: The results of this study imply that about 4–8% of the general adult Amsterdam population is still susceptible to infection with VZV, and that susceptibility is even higher in some immigrant groups. When assessing the risk of infection after VZV exposure alertness is needed for vulnerable persons like pregnant women, patients with hematological malignancies or organ transplants in particular among first-generation immigrants.
format Online
Article
Text
id pubmed-3434062
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34340622012-09-06 Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population van Rijckevorsel, Gini GC Damen, Marjolein Sonder, Gerard J van der Loeff, Maarten F Schim van den Hoek, Anneke BMC Infect Dis Research Article BACKGROUND: In the Netherlands, infection with varicella-zoster virus (VZV) is considered a benign common childhood illness and routine vaccination against VZV is not done. In 1995 it was estimated that 98-100% of the adult Dutch general population is immune, yet the estimate is based on a database in which a relative small number of people of non-Dutch ethnic origin were represented. As the city of Amsterdam has large immigrant communities originating from various subtropical and tropical countries, such as Morocco, Surinam, and Turkey with probably lower VZV transmission, this study aimed to estimate the seroprevalence of VZV IgG antibodies (anti-VZV) among various ethnic groups in Amsterdam, and identify factors associated with seronegative VZV status. METHODS: The study was a cross-sectional survey of the Amsterdam population (2004), and the study sample was stratified by age and ethnicity, with deliberate oversampling of minority ethnic groups. Serum samples obtained from 1,341 residents in 2004 were tested for antibodies to VZV. Basic demographic data (gender, age, country of birth, age at immigration and number of children) were also available. RESULTS: The anti-VZV seroprevalence in the overall Amsterdam population was estimated to be 94% (95% confidence intervals; 92–96%). Regarding ethnic origin, first generation immigrants (Moroccan immigrants 90%, Surinamese or Antillean immigrants 91%, and Turkish 92%), especially those that migrated after the age of 11 years, were more likely to be anti-VZV seronegative compared to those arriving at an earlier age or those born in the Netherlands (97–98%). Both ethnic origin and generation of immigration were positive predictors for IgG seronegativity to VZV (p<0.015). No other predictors for seronegativity were found. CONCLUSION: The results of this study imply that about 4–8% of the general adult Amsterdam population is still susceptible to infection with VZV, and that susceptibility is even higher in some immigrant groups. When assessing the risk of infection after VZV exposure alertness is needed for vulnerable persons like pregnant women, patients with hematological malignancies or organ transplants in particular among first-generation immigrants. BioMed Central 2012-06-21 /pmc/articles/PMC3434062/ /pubmed/22721551 http://dx.doi.org/10.1186/1471-2334-12-140 Text en Copyright ©2012 van Rijckevorsel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
van Rijckevorsel, Gini GC
Damen, Marjolein
Sonder, Gerard J
van der Loeff, Maarten F Schim
van den Hoek, Anneke
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title_full Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title_fullStr Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title_full_unstemmed Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title_short Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
title_sort seroprevalence of varicella-zoster virus and predictors for seronegativity in the amsterdam adult population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434062/
https://www.ncbi.nlm.nih.gov/pubmed/22721551
http://dx.doi.org/10.1186/1471-2334-12-140
work_keys_str_mv AT vanrijckevorselginigc seroprevalenceofvaricellazostervirusandpredictorsforseronegativityintheamsterdamadultpopulation
AT damenmarjolein seroprevalenceofvaricellazostervirusandpredictorsforseronegativityintheamsterdamadultpopulation
AT sondergerardj seroprevalenceofvaricellazostervirusandpredictorsforseronegativityintheamsterdamadultpopulation
AT vanderloeffmaartenfschim seroprevalenceofvaricellazostervirusandpredictorsforseronegativityintheamsterdamadultpopulation
AT vandenhoekanneke seroprevalenceofvaricellazostervirusandpredictorsforseronegativityintheamsterdamadultpopulation